BUXBiomark Diagnostics Inc

CNQ · CA · Healthcare · Diagnostics & Research · biomarkdiagnostics.com

0.5600CAD+1.82%Mkt Cap: 42.86M $P/E: —25d ago

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of l…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap42.86M $

Enterprise Value39.07M $

Revenue (TTM)43.54K $

Gross Profit43.54K $

Net Income (TTM)-1.08M $

Revenue/Share0.0007 USD

Last Price0.5600 CAD

Fiscal Year EndMar 2026

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-31.48

EV/Revenue897.37

P/S878.87

P/B166.67

EPS (TTM)-0.01

EPS (Forward)—

52W Range

0.270078% of range0.6400

52W High0.6400 CAD

52W Low0.2700 CAD

Profitability

Gross Margin100.00%

Oper. Margin-5030.37%

EBITDA Margin0.00%

Profit Margin-2470.76%

ROE-446.20%

ROA-79.40%

Growth

Revenue Growth-82.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF-792.92K $

CapEx (TTM)3.08K $

FCF Margin-1290.22%

FCF Yield-1.31%

Net Debt298.22K $

Net Debt/EBITDA-0.24

Balance Sheet

Debt/Equity2.19

Current Ratio0.99

Quick Ratio0.97

Book Value/Sh0.0030 CAD

Cash/Share0.0090 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.105.09M

Float48.60M

Insiders48.47%

Institutions0.00%

Short Interest

Short Ratio0.2d

Short % Out.0.00%

Shares Short879

Short (prev mo.)396

Technical

SMA 500.5510 (+1.6%)

SMA 2000.5337 (+4.9%)

Beta-0.31

S&P 52W Chg18.16%

Avg Vol (30d)3.99K

Avg Vol (10d)5.82K

Technical Indicators

RSI (14)62.9

MACD-0.0007

MACD Signal-0.0023

MACD Hist.+0.0016

BB Upper0.5602 CAD

BB Middle0.5485 CAD

BB Lower0.5368 CAD

BB Width4.28%

ATR (14)0.0080 CAD

Vol Ratio (20d)0.60x